CAPR
Capricor Therapeutics IncNASDAQHEALTHCAREBIOTECHNOLOGY
Key Statistics
Market Cap
$1.75B
P/E Ratio
—
EPS
$-2.32
Beta
0.48
52W High
$40.37
52W Low
$4.30
50-Day MA
$31.84
200-Day MA
$18.84
Dividend Yield
—
Profit Margin
0.00%
Forward P/E
78.74
PEG Ratio
0.38
About Capricor Therapeutics Inc
Capricor Therapeutics, Inc., a biotechnology company, focuses on the development of transformative cell- and exosome-based therapies for the treatment and prevention of a broad spectrum of diseases. The company is headquartered in Beverly Hills, California.
Fundamentals
| Revenue (TTM) | $11.13M |
| Gross Profit (TTM) | $-92.92M |
| EBITDA | $-117.98M |
| Operating Margin | 0.00% |
| Return on Equity | -46.60% |
| Return on Assets | -25.70% |
| Revenue/Share (TTM) | $0.24 |
| Book Value | $5.33 |
| Price-to-Book | 5.75 |
| Price-to-Sales (TTM) | 124.43 |
| EV/Revenue | 141.52 |
| EV/EBITDA | -2.73 |
| Quarterly Earnings Growth (YoY) | 0.00% |
| Quarterly Revenue Growth (YoY) | -7.90% |
| Shares Outstanding | $57.84M |
| Float | $48.74M |
| % Insiders | 9.47% |
| % Institutions | 56.90% |
Historical Volatility
HV 10-Day
95.43%
HV 20-Day
72.29%
HV 30-Day
69.54%
HV 60-Day
76.93%
HV Rank
—
Volatility is currently expanding
Analyst Ratings
Consensus ($54.67 target)
2
Strong Buy7
BuyMore HEALTHCARE Stocks
Data last updated: 5/14/2026